What are the symptoms of an arteriovenous malformation (AVM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Arteriovenous Malformations (AVMs)

The most common presenting symptom of brain AVMs is intracranial hemorrhage, occurring in 50-60% of all cases, followed by seizures (20-25%) and headaches (15%). 1, 2

Primary Clinical Presentations

Hemorrhagic Presentation (Most Common)

  • Intracranial hemorrhage is the initial symptom in approximately half of all AVM patients, representing the most frequent mode of discovery 2, 3
  • In pediatric populations, more than 75% of symptomatic AVMs present with hemorrhage 4, 2
  • Hemorrhage carries significant consequences: mortality ranges from 10-30% for first hemorrhage, with 10-20% of survivors experiencing permanent neurological disability 1, 2
  • The risk of recurrent hemorrhage is substantially elevated in the first year after initial bleeding, ranging from 6% to 32.9% depending on the study 4, 2

Seizure Presentation

  • Seizures occur as the presenting symptom in 20-25% of adult AVM cases 2
  • Seizures are more common in adults than children as an initial presentation 2
  • Some evidence suggests patients presenting with seizures may be at slightly higher risk for subsequent hemorrhage, though this finding is inconsistent 4

Headache Presentation

  • Headaches are the presenting symptom in approximately 15% of AVM cases 2
  • These headaches can be chronic or acute in nature 5

Focal Neurological Deficits

  • Focal neurological deficits can occur without obvious hemorrhage, resulting from mass effect or vascular steal phenomenon 4, 5
  • Deficits may be fixed or progressive over time 5

Age-Specific Presentations

Neonatal and Infant Presentations

  • Symptomatic neonates often present with unexplained high-output cardiac failure, and these patients tend to have worse outcomes 4
  • Infants may develop hydrocephalus, particularly with posterior fossa lesions causing vein of Galen aneurysmal dilatation and aqueductal compression 4

Pediatric Presentations

  • Children predominantly present with hemorrhage (>75% of symptomatic cases) rather than other symptoms 4, 2
  • The remaining pediatric cases present with seizures, headaches, or focal deficits 4

Adult Presentations

  • Adults show more varied presentations: hemorrhage (50-60%), seizures (20-25%), headaches (15%), or focal deficits 2
  • AVMs can remain clinically silent for decades before becoming symptomatic 2

Less Common Presentations

Intracranial Hypertension

  • Isolated intracranial hypertension mimicking pseudotumor cerebri can occur occasionally 4

Incidental Discovery

  • Incidental AVMs are being diagnosed with increasing frequency due to widespread use of noninvasive neuroimaging 3
  • These asymptomatic lesions are discovered during imaging performed for unrelated reasons 3

Associated Genetic Conditions

Hereditary Hemorrhagic Telangiectasia (HHT)

  • Approximately 70-90% of pulmonary AVMs are associated with HHT, an autosomal dominant disorder 1
  • Multiple AVMs should prompt consideration of hereditary hemorrhagic telangiectasia 4

Familial AVMs

  • Familial AVMs have been described in families without specific genetic vascular conditions 4
  • Multiple AVMs in the same individual are relatively common 4

Clinical Pitfalls and Important Considerations

  • The absence of symptoms does not eliminate hemorrhage risk: unruptured AVMs carry a 2-4% annual hemorrhage risk 4
  • Prior hemorrhage is the strongest predictor of future bleeding, making it a critical historical feature 4, 2
  • Small AVM size paradoxically may be associated with higher hemorrhage risk, contrary to intuitive expectations 4, 2
  • Comprehensive evaluation requires both detailed clinical examination and radiological clarification with MRI and arteriography after symptom presentation 4
  • The lifetime risk of hemorrhage can be approximated by the formula: Lifetime risk (%) = 105 - patient's age in years 4, 2

References

Guideline

Stable Right Upper Lobe Arteriovenous Malformation (AVM)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brain Arteriovenous Malformations (AVMs) Development and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of patients with brain arteriovenous malformations.

European journal of radiology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.